Current promising treatment strategy for glioblastoma multiform: A review
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.417
Advances in pancreatic cancer biomarkers
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.410
Potential effect of probiotics in the treatment of breast cancer
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.422
Prospects for repurposing CNS drugs for cancer treatment
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.411
A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.409
Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.425
CDK4/6 inhibitors in advanced breast cancer, what is beyond?
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.416
Thrombocytopenia in solid tumors: Prognostic significance
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.413
Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.424
Prognostic significance of aberrant CD5 expression in B-cell leukemia
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.400
Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.376
MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.403
Therapeutic options for ampullary carcinomas. A review
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.440
Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.433
Adherence to oral pharmacological treatment in cancer patients: Systematic review
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.402
Physiopathology and diagnosis of cardiotoxicity in patients submitted to chemotherapy treatment
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.383
Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.387
Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.455
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.430
Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.389
Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.435
Prognostic significance of mutated genes in megakaryocytic disorders
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.408
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.377
Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
来源期刊:Oncology ReviewsDOI:10.4081/oncol.2019.421